Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Molecular Templates Inc (MTEM)
NASDAQ:MTEM
Molecular Templates (MTEM) Stock Price & Analysis
490 Followers
MTEM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.31 - $3.64
Previous Close$0.53
Volume175.69K
Average Volume (3M)164.61K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$79.44M
Total Debt (Recent Filing)$50.32M
Price to Earnings (P/E)-0.4
Beta1.09
Next EarningsMar 29, 2023
EPS Estimate-$0.32
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$1.00
EPS (TTM)-1.44
Shares Outstanding56,351,647
R-Squared0.11
Standard Deviation0.20
10 Day Avg. Volume126,034
30 Day Avg. Volume164,610
Price to Book (P/B)6.24
Price to Sales (P/S)1.64
Price to Cash Flow (P/CF)23.40
P/FCF Ratio-0.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside89.29% Upside
Rating ConsensusModerate Buy
Alpha-0.04
Number of Analyst Covering1
Molecular Templates News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MTEM FAQ
What was Molecular Templates’s price range in the past 12 months?
Molecular Templates lowest stock price was $0.31 and its highest was $3.64 in the past 12 months.
What is Molecular Templates’s market cap?
Currently, no data Available
When is Molecular Templates’s upcoming earnings report date?
Molecular Templates’s upcoming earnings report date is Mar 29, 2023 which is in 61 days.
How were Molecular Templates’s earnings last quarter?
Molecular Templates released its earnings results on Nov 10, 2022. The company reported -$0.44 earnings per share for the quarter, beating the consensus estimate of -$0.486 by $0.046.
Is Molecular Templates overvalued?
According to Wall Street analysts Molecular Templates’s price is currently Undervalued.
Does Molecular Templates pay dividends?
Molecular Templates does not currently pay dividends.
What is Molecular Templates’s EPS estimate?
Molecular Templates’s EPS estimate is -$0.32.
How many shares outstanding does Molecular Templates have?
Molecular Templates has 56,351,646 shares outstanding.
What happened to Molecular Templates’s price movement after its last earnings report?
Molecular Templates reported an EPS of -$0.44 in its last earnings report, beating expectations of -$0.486. Following the earnings report the stock price went up 7.143%.
Which hedge fund is a major shareholder of Molecular Templates?
Among the largest hedge funds holding Molecular Templates’s share is Woodline Partners LP. It holds Molecular Templates’s shares valued at N/A.
---
Molecular Templates Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1.00
$1.00
Hedge Fund Trend
Decreased
By 496.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 7.6%
Last 30 Days ▼ 7.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-82.22%
12-Months-Change
Fundamentals
Return on Equity
-212.21%
Trailing 12-Months
Asset Growth
-45.56%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Molecular Templates Inc
Molecular Templates, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. The company utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. Molecular Templates was founded on October 17, 2001 and is headquartered in Austin, TX.
---
Vicapsys Life Sciences
―
Arca Biopharma
―
Pasithea Therapeutics Corp
―
Comera Life Sciences Holdings
―
NightHawk Biosciences
―
---